






































Accumulation of DNA damage is a hallmark of genome 
instability and is associated with both aging and cancer 
[1-3]. Mice deficient in proteins involved in DNA 
damage sensing and repair exhibit severe deficiencies in 
these pathways leading to accelerated aging and 
oncogenic transformation [4]. Many progeria (prema-
ture aging) syndromes in humans are caused by 
mutations in genes encoding  proteins involved in  DNA  
repair and are associated with increased incidence of 
cancer [5, 6]. 
 
One major type of DNA lesion leading genomic 
instability is DNA double-strand damage, which includes 
both telomere-independent DNA double-stand  breaks  
 
 





































































(DSBs) and damaged telomeres (see schematic in Figure 
1). Telomere-independent DSBs, which localize at 
chromosome arms, can be induced by a variety of agents 
including ionizing radiation, radiomimetic drugs, 
reactive oxygen species, metabolic errors during 
replication and transcription, and deficient DNA repair 
[7]. Telomeric damage is chromosome end-specific and 
includes two types of lesions, DNA double-strand ends 
which are the consequence of telomere dysfunction, and 
DNA DSBs at telomeres.   
 
Immediately upon DNA double-strand damage 
formation, hundreds of histone H2AX molecules are 
phosphorylated at the break site to form γ-H2AX foci. 
This characteristic makes γ-H2AX foci a sensitive 
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possible by the use of antibodies to γ-H2AX, is that 
cells that have not been subjected to deliberate damage 
still contain endogenous DSB damage. This endogenous 
DNA DSB damage is present at low levels in early 
passage primary cells, but it increases in human and 
mouse cells during in vivo aging and in vitro cellular 
senescence [3, 8, 9]. Increased and variable levels of 
DNA DSBs have also been found in premalignant 
lesions, tumor cell lines and tumors of different origins 
[2, 10-13]. The endogenous γ-H2AX foci contain DNA 
DSB repair factors such as 53BP1, MRE11, RAD50, 
and NBS1, indicating that DNA DSB repair is being 
attempted at these sites [3, 9]. 
 
The existence of non-telomeric DNA DSBs and 
telomeres-associated endogenous DNA double-strand 
damage creates confusion about which type of damage 
is present. The confusion can be clarified by 
determining the location of the γ-H2AX foci on the 
chromosomes. When this type of analysis was 
performed on human and mouse senescent cells, both 
were found to contain similar levels of total endogenous 
DNA DSB damage, but differing contributions from 
non-telomeric DSBs and damaged telomeres. This 
comparison of human and mouse cells suggested that 
both telomere-independent and telomere-associated 
damage may be similarly involved in the signaling to 
induce cellular senescence and organismal aging [14]. 
 
In the present study we performed this analysis on five 
tumor cell lines to clarify the relative contribution of 
telomeric damage to the high level of endogenous DNA 
damage in tumors. We report that the numbers of non-
telomeric DNA DSBs, as measured by γ-H2AX foci 
present at chromosome arms, were remarkably similar 
across all cultures studied. However, the numbers of γ-
H2AX foci associated with telomeres varied 
considerably and correlated inversely with telomerase 
activity. These results indicate that human tumor cells 
contain substantial and variable numbers of 
dysfunctional telomeres, which account for most of the 
variation in the number of γ-H2AX foci in different 




Distribution of γ-H2AX foci in proliferating tumor 
cell cultures 
 
  In contrast to senescent cells, which contain similar 
numbers of endogenous γ-H2AX foci irrespective of 
origin [14], malignant cells have higher DSB levels 
which vary greatly in different cultures and tumors [10, 
12, 13]. We performed parallel analyses of γ-H2AX foci 
in undamaged cultures of five tumor cell lines of 
different origins, HeLa, SiHa, and SW756 (cervical 
carcinomas); HCT116 (colon carcinoma) and M059K 
(glioblastoma) (Figure 2). Endogenous γ-H2AX levels 
in these cultures have been shown earlier to vary 
widely, from an average of 1.1 γ-H2AX foci per cell in 
M059K cells to as high as 46 foci per cell in SW756 
cells [10, 13]. Additionally, comparison of DNA 
damage in 6 intact cervical carcinoma cell lines showed 
great variability in γ-H2AX focal numbers, indicating 
that endogenous DNA damage is independent of tumor 
origin [10]. In this study we counted γ-H2AX foci in 
interphase in large cell populations (400 - 600 cells) of 
the five lines, and found an average of 6.6 -10.6 foci per 
cell (Figure 2A, B).  Cultures of the same tumor line 
yielded average numbers of γ-H2AX foci per cell that 
varied by over two-fold in three independent 
experiments, indicating that focal numbers are 
dependent on culture conditions (Figure 2B). In 
addition, in these three experiments, the standard 
deviations were often larger than the average values for 
the number of γ-H2AX foci per cell, indicating a large 
amount of heterogeneity in the population. The cause of 
these large standard deviations may be explained by 
data shown in Figure 2C. In each tumor line, while the 
majority of the cells contained less than 10 foci per cell, 
there was a substantial fraction of cells that contained 
larger numbers of γ-H2AX foci, up to about 50 per cell, 
creating a long tail in the distribution and leading to 
large standard deviations from the average.  
 
The counts we present here are different from published 
data for these cell lines. We account for this discrepancy 
by possible bias caused by a great disparity in the 
number of γ-H2AX foci in a cell population, in the focal 
sizes and intensities (Figure 2A), and by variations in 
the cells’ proliferative status, as well as their checkpoint 
status and expression of p53 or other proteins involved 
in genomic stability that could have changed due to 
genetic drift over time. Therefore, since counting γ-
H2AX  foci  in interphase tumor cells can provide only 
limited information, studies in metaphase cells were 
performed to allow visualization of truly informative 
foci by avoiding at least some of these problems, such 
as proliferative status and focal variability.  
 
Origins of endogenous γ-H2AX foci in metaphase 
tumor cells 
 
Yu et al. reported that tumor cell cultures exhibited 
large numbers of endogenous γ-H2AX foci per cell, 
sometimes equivalent to several Gy of ionizing 
radiation. Strikingly however, they found no difference 
in  tail  moments  when  these cultures were identically  
   



















irradiated and the cells were analyzed by the comet 
assay [12]. This discrepancy suggests the hypothesis 
that a substantial fraction of the endogenous γ-H2AX 
foci might be marking uncapped telomeres rather than 
DSBs. Since the damage is at the end of the DNA, the 
comet or any other DNA fragmentation assay would not 
detect it. To examine this notion, we analyzed 
metaphases of five tumor cell lines for γ-H2AX and 
telomeric DNA FISH signals to score the numbers of 
telomere-associated and telomere-independent  γ-H2AX 
foci (Figure 3). This procedure permits the localization 
of  γ-H2AX foci to either the chromatid arms, 
corresponding to DNA DSBs of non-telomeric origin, 
or to the ends of the chromatids, corresponding to either 
DSB-damaged telomeres (FISH-positive terminal foci), 
or double-strand ends at critically short telomeres 
lacking detectable telomere repeats (FISH-negative 
foci) (Figure 3A, B).  
 
When the distribution of γ-H2AX foci on metaphase 
spreads was analyzed, the total numbers per cell varied 
similarly to the average number of foci found in the 
interphase nuclei (Figure 3C, black bars). Strikingly, the 
numbers of γ-H2AX foci along the chromosome arms 
were found to be similar in all cell lines (Figure 3C, 
gray bars). In fact, in four of the cell lines the numbers 
were the same within the standard error, with an 
average of 2.6 foci per cell. Only HCT116 exhibited a 
different number of γ-H2AX foci on chromatid arms, 
4.7 per cell. These results suggest that the number of 
DNA DSBs may have fairly constant values among 
tumor lines. In contrast, the numbers of telomeric γ-
H2AX  foci  were  more  variable  among the five lines 
(Figure 3C, blue bars), suggesting that the differences in 


















Figure  1.  Types  of  endogenous  DNA 
double‐strand  damage  marked  by  γ‐
H2AX  foci.  The  endogenous  DNA  double‐
strand damage that induces H2AX phosphor‐
rylation  includes  both  non‐telomeric  DNA 
double‐stand  breaks  (DSBs)  located  at 
chromatid  arms  and  damaged  telomeres. 
Telomeric  damage  is  a  chromo‐some  end‐
specific damage which includes two types of 










variations in the number of damaged telomeres. When 
the damaged  telomeres containing  γ-H2AX foci  were  
classified as to whether they were FISH positive or 
negative, the majority were found to be FISH negative, 
confirming that telomeres were critically short (Figure 
3D).  
 
We next analyzed the metaphase spread data to discern 
the distribution of telomeric and non-telomeric γ-H2AX 
foci in the cells with increasing numbers of total foci 
(Figure 3E). This analysis demonstrates that in cells that 
contain more than the average number of γ-H2AX foci, 
the increase is almost completely due to telomeric foci. 
This result indicates that tumor cells maintain a fairy 
constant level of non-telomeric DNA DSBs irrespective 
of the total DNA damage, and it is damaged telomeres 
that become more plentiful in these cells. Similar analysis 
of the distribution of FISH-negative and FISH-positive 
telomeric  γ-H2AX foci indicates that among the total 
telomeric foci per metaphase, critically short telomeres 
account for disparities (Figure 3F). 
 
A defining characteristic of cancer cells is the presence 
of telomerase, which permits these cells to divide 
indefinitely [15, 16]. Since telomeres are maintained 
by telomerase, which catalyzes the addition of 
telomeric DNA repeats to the chromosome ends [17, 
18], we asked whether the average telomerase activity 
correlated with the average numbers of γ-H2AX foci 
in the five studied tumor lines. We found an inverse 
relationship between the numbers of γ-H2AX foci and 
telomerase activity (Figure 3G). These results indicate 
that the level of telomerase in a tumor cell line is a 
major determinant of the average number of γ-H2AX 
foci.  
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The purpose of this study was to determine how much 
of the DNA double-strand damage in tumor cells is 
actually due to damaged telomeres. The results clearly 
show that damaged telomeres make up the majority of 
DNA double-strand damage in tumor cells, and that 
cells with more foci contained more damaged 
telomeres, while the numbers of telomere-independent 
DSBs remained fairly constant throughout the 
population. The numbers of endogenous telomeric γ-
H2AX foci in metaphases correlated inversely with 
telomerase activity in these cell lines, confirming the 
importance of telomerase in malignant phenotypes. 
These data parallel our recently published findings for 
senescent cells which also contain elevated γ-H2AX 
foci compared to actively growing low population 
doubling cultures, which in humans have mainly 
telomere-associated origins [14]. Telomere shortening 
and consequent telomere dysfunction or uncapping are 
associated with many human diseases including aging 
and cancer, and have received a great deal of attention 
(reviewed in [19, 20]). Genomic alterations observed in 
human cancers can be caused by inappropriate DNA 
repair taking place at dysfunctional telomeres leading to 
loss of heterozygosity, chromoso-mal rearrangements, 
aneuploidy, and repression of DNA damage 
checkpoints [21].  Shorter telomeres have been 
associated with increased cancer risk [22]. Differences 
in telomere-associated DNA damage in different tumor 
cell lines can be explained partly by the fact that these 
cell lines have been derived from different individuals, 
thus telomere lengths are affected by the cellular 
activity of telomerase, the cells’ history of cell division 
and environmental factors. Additionally, as the tumor 
lines were isolated many years ago, they may have 
changed due to genetic drift. Finally, telomere length is 
tissue-specific, and age-dependent [23, 24], and there is 
considerable heterogeneity between humans [25].  
 
Telomerase expression is one of the most clearly 
distinguishable characteristics between malignant and 
primary healthy cells [15] which makes it a suitable 
target for cancer therapy. Inhibiting telomerase activity 
in tumor cells may increase the number of damaged 
telomeres and thereby limit proliferation. Many 
telomerase inhibitors are now going through clinical 
trials [26]. However, previously there was no tool to 
analyze whether tumors show different sensitivity for 
telomerase inhibitors and to control this sensitivity. 
Here we show that each tumor cell line has a signature 
amount of telomere-associated DNA damage. There-
fore, telomerase inhibitors or telomere maintenance-
targeting drugs could affect different tumors with 
differing success, and analysis of telomere-associated γ-
H2AX focal numbers in primary tumors treated with 
telomerase-based drugs could be used to monitor the 
drug efficiency. In addition, many cancer drugs act by 
introducing sufficient excess DNA damage into a tumor 
cell to prevent further proliferation. The procedure 
presented here enables researchers to determine the 
extent of the two types of DNA double-strand damage, 
both of which are relevant to cancer treatment, and 
provides useful information for developing tailor-made 




Cell cultures. HeLa, SiHa and SW756 (cervical 
carcinomas), HCT116 (colon carcinoma), and M059K 
(glioblastoma) cell lines were obtained from ATCC 
(Manassas, VA) and grown in D-MEM medium 
containing 10% fetal bovine serum. Cells were 
maintained in a humidified incubator at 37ºC, 5% CO2 
and 20% O2.  
 
Immunocytochemistry. Cell cultures were plated on 
Labtek II slides (Nalge Nunc International, Naperville, 
IL). After the cultures reached 80% confluency, they 
were fixed with 2% paraformaldehyde for 20 min. Then 
the cells were washed 4 times with PBS, permeabilized 
with pre-chilled 70% ethanol at -20ºC and stored 
overnight at 4ºC. PBS was replaced with PBS 
containing 0.5% Tween-20 and 0.1% Triton X-100 
(Bio-Rad Laboratories, Hercules, CA) for blocking and 
antibody incubations. The samples were stained with 
primary mouse monoclonal anti-γ-H2AX antibody 
(Abcam Inc., Cambridge, MA) followed by secondary 
Alexa-488-conjugated anti-mouse IgG (Molecular 
Probes, Eugene, OR). Nuclei were counterstained with 
DAPI (4,6-diamidino-2-phenylindole-dihydrochroride). 
Images were acquired with the BD Pathway Bioimager 
and processed with Attovision software (Becton 
Dickinson Biosciences, San LoseJose, CA). γ-H2AX 
foci were counted by eye in three independent 
experiments, in a total of 400-600 cell nuclei.  
 
Immunocytochemistry and FISH. Metaphase spreads 
were prepared as described previously [27]. The slides 
were stained with mouse monoclonal anti-γ-H2AX 
antibody followed by Alexa-488-conjugated anti-mouse 
IgG. The staining with both γ-H2AX and telomere FISH 
was performed according to the telomere FISH kit 
(DakoCytomation, Glostrup, Denmark) protocol with 
some modifications. Briefly, the γ-H2AX stained cells 
were fixed with 50 mM ethylene glycol-bis (succinic 
acid N-hydroxy-succinimide ester) (Sigma, St. Louis, 
MO). The hybridization was performed according to the 
kit protocol. DAPI was used for visualization of DNA. 
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microscope (Olympus America Inc. Melville, NY). 
 
Telomerase assay. Telomerase activity in tumor cell 
lines was analyzed using the TRAPeze Telomerase 
Detection Kit (Chemicon International a division of 
Serologicals Co., Temecula, CA). Cell extracts, 
prepared according to the manufacturer's instructions, 
were assayed for telomerase activity in 50 µL reactions 
provided with the TRAPeze Telomerase Detection Kit 
with the exception of Platinum Taq DNA polymerase 
(Invitrogen, Eugene, OR). The reaction mixtures were 
size-fractionated by electrophoresis in a 10% non-
denaturating polyacrylamide gel and stained with SYBR 
Green 1 dye (Sigma). The gels were photographed 
using the Typhoon 8600 system (Amersham Pharmacia 
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